|
GNL3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.007930E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.284400E-02 |
| Normal-vs-Stage2 |
1.679230E-01 |
| Normal-vs-Stage3 |
3.003800E-01 |
| Normal-vs-Stage4 |
1.075930E-03 |
| Stage1-vs-Stage2 |
5.351600E-01 |
| Stage1-vs-Stage3 |
2.727600E-01 |
| Stage1-vs-Stage4 |
2.532200E-02 |
| Stage2-vs-Stage3 |
7.141600E-01 |
| Stage2-vs-Stage4 |
1.550110E-02 |
| Stage3-vs-Stage4 |
7.944000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.115900E-02 |
| Normal-vs-AfricanAmerican |
1.303360E-03 |
| Normal-vs-Asian |
8.159800E-02 |
| Caucasian-vs-AfricanAmerican |
1.422130E-02 |
| Caucasian-vs-Asian |
3.864800E-01 |
| AfricanAmerican-vs-Asian |
9.161600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.394000E-02 |
| Normal-vs-Female |
8.102100E-03 |
| Male-vs-Female |
2.207800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.097500E-02 |
| Normal-vs-Age(41-60Yrs) |
5.617600E-02 |
| Normal-vs-Age(61-80Yrs) |
4.536900E-03 |
| Normal-vs-Age(81-100Yrs) |
6.265800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.902200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.693800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.009800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.809600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.717900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.779000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.208620E-01 |
| Normal-vs-Grade 2 |
1.599650E-02 |
| Normal-vs-Grade 3 |
3.231000E-01 |
| Normal-vs-Grade 4 |
9.175800E-04 |
| Grade 1-vs-Grade 2 |
7.178600E-01 |
| Grade 1-vs-Grade 3 |
3.090200E-01 |
| Grade 1-vs-Grade 4 |
2.304400E-01 |
| Grade 2-vs-Grade 3 |
5.447700E-02 |
| Grade 2-vs-Grade 4 |
3.164400E-02 |
| Grade 3-vs-Grade 4 |
3.196700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.313000E-01 |
| Normal-vs-ccB subtype |
5.764700E-04 |
| ccA subtype-vs-ccB subtype |
1.183240E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.024400E-02 |
| Normal-vs-N1 |
3.922000E-02 |
| N0-vs-N1 |
9.813700E-02 |
|
|
